Phase 2 Frontotemporal Dementia Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
Frontotemporal DementiaFTDDementia, Frontotemporal+1 more
AviadoBio Ltd18 enrolled19 locationsNCT06064890
Recruiting
Phase 1Phase 2
A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes
Frontotemporal DementiaFTDFTD-GRN
Passage Bio, Inc.30 enrolled10 locationsNCT04747431
Recruiting
Phase 1Phase 2
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
DementiaAlzheimer DiseaseFrontotemporal Dementia
David Wilson102 enrolled1 locationNCT05374278
Recruiting
Phase 2
Nabilone for Agitation in Frontotemporal Dementia
Frontotemporal DementiaPrimary Progressive AphasiaFTD+3 more
Simon Ducharme, MD45 enrolled7 locationsNCT05742698
Recruiting
Phase 2
Investigating sodium selenate as a treatment for behavioural variant frontotemporal dementia
behavioural variant frontotemporal dementia
Alfred Health120 enrolled5 locationsACTRN12620000236998